Attacking the HIV Reservoir from the Immune and Viral Perspective

作者: Marta Massanella , Javier Martinez-Picado , Julià Blanco

DOI: 10.1007/S11904-012-0150-8

关键词: Proviral dnaVirologyHuman immunodeficiency virus (HIV)Disease EradicationImmune systemVirusImmunologyInflammationViral replicationAntiretroviral therapyBiology

摘要: Upon HIV infection, a subset of latently infected cells carrying transcriptionally inactive integrated proviral DNA (the HIV-1 reservoir) is rapidly established. These are the main force behind persistence under highly active antiretroviral therapy (HAART), which only impacts on actively replicating viruses and it therefore unable to eradicate infection. However, case Timothy Brown, also known as Berlin patient, demonstrates that eradication possible, recent data support idea latency may be reverted in vivo, suggesting possible perturb reservoir. This achieved by implementing both pharmacological immunological strategies reactivate from cells. Nevertheless, reactivation might not sufficient virus. Reinforcing HIV-1-specific immune responses blocking potential new events viral replication will probably help reaching final goal or alternative objective functional cure for HIV-1.

参考文章(110)
知之 遠藤, 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention HIV感染症とAIDSの治療. ,vol. 2, pp. 89- 93 ,(2011)
Tae-Wook Chun, Delphine Engel, Stephanie B. Mizell, Claire W. Hallahan, Maria Fischette, Sohee Park, Richard T. Davey, Mark Dybul, Joseph A. Kovacs, Julia A. Metcalf, JoAnn M. Mican, M. Michelle Berrey, Lawrence Corey, H. Clifford Lane, Anthony S. Fauci, Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy Nature Medicine. ,vol. 5, pp. 651- 655 ,(1999) , 10.1038/9498
Sian M. Henson, Arne N. Akbar, Memory T-Cell Homeostasis and Senescence during Aging Memory T Cells. ,vol. 684, pp. 189- 197 ,(2010) , 10.1007/978-1-4419-6451-9_15
Strategies for Management of Antiretroviral Therapy (SMART) Study Group, None, Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up The Journal of Infectious Diseases. ,vol. 197, pp. 1145- 1155 ,(2008) , 10.1086/529523
MONTE S. MELTZER, MARIKO NAKAMURA, BRIAN D. HANSEN, JIM A. TURPIN, D. CHESTER KALTER, HOWARD E. GENDELMAN, Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Research and Human Retroviruses. ,vol. 6, pp. 967- 971 ,(1990) , 10.1089/AID.1990.6.967
Nancy M Archin, Joseph J Eron, Sarah Palmer, Anne Hartmann-Duff, Jeffery A Martinson, Ann Wiegand, Nicholas Bandarenko, John L Schmitz, Ronald J Bosch, Alan L Landay, John M Coffin, David M Margolis, Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS. ,vol. 22, pp. 1131- 1135 ,(2008) , 10.1097/QAD.0B013E3282FD6DF4
Jessica E. Bolden, Melissa J. Peart, Ricky W. Johnstone, Anticancer activities of histone deacetylase inhibitors Nature Reviews Drug Discovery. ,vol. 5, pp. 769- 784 ,(2006) , 10.1038/NRD2133
Anita Parmigiani, Maria F. Pallin, Helena Schmidtmayerova, Mathias G. Lichtenheld, Savita Pahwa, Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells. Human Immunology. ,vol. 72, pp. 115- 123 ,(2011) , 10.1016/J.HUMIMM.2010.10.015
Laurent Hocqueloux, Thierry Prazuck, Véronique Avettand-Fenoel, Alain Lafeuillade, Bernard Cardon, Jean-Paul Viard, Christine Rouzioux, Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection AIDS. ,vol. 24, pp. 1598- 1601 ,(2010) , 10.1097/QAD.0B013E32833B61BA
J. Friedman, W.-K. Cho, C. K. Chu, K. S. Keedy, N. M. Archin, D. M. Margolis, J. Karn, Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2 Journal of Virology. ,vol. 85, pp. 9078- 9089 ,(2011) , 10.1128/JVI.00836-11